Results 111 to 120 of about 14,877 (300)

Intracoronary reopro during percutaneous coronary intervention in acute and stable patient can influence stent thrombosis formation (IRPASST) study

open access: yesHeart Views, 2013
Background: In patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty, abciximab reduces major adverse cardiac events (MACE). Most clinical trials have studied mainly intravenous administration.
Mohammed Balghith   +3 more
doaj  

Primary Coronary Angioplasty in the Elderly [PDF]

open access: yes, 2005
Introdução: A angioplastia primária é a terapêutica de reperfusão com melhores resultados no enfarte agudo do miocárdio (EAM). Este facto assume particular relevância na população acima dos 75 anos, em que o risco hemorrágico relacionado com a trombólise
Cacela, D   +8 more
core  

Antiagregación y anticoagulación en síndromes coronarios agudos: niveles de evidencia [PDF]

open access: yes, 2007
Management of acute coronary syndromes (ACS) has moved rapidly in parallel with our understanding of the pathophysiological basis of the disease. In the eighties, the demonstration of the pivotal role of coronary thrombosis in the etiology of a ACS led ...
Garcia, R. (R.)   +3 more
core  

Abciximab in Acute Ischemic Stroke [PDF]

open access: bronze, 2000
The Abciximab in Ischemic Stroke Investigators
openalex   +1 more source

Importance of Complex Additional Stenosis After Primary Angioplasty for Acute Myocardial Infarction in Medium-Term Prognosis [PDF]

open access: yes, 2004
Introdução: Existe alguma controvérsia respeitante ao tipo de revascularização a efectuar no contexto de angioplastia (PCI) primária no enfarte agudo do miocárdio (EAM).
Cruz Ferreira, R   +6 more
core  

Successful systemic thrombolysis for carotid stent thrombosis [PDF]

open access: yes, 2002
Hamann, Gerhard F.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy